GATC Biotech AG Sustainability Profile
GATC Biotech AG, a leading player in the biotechnology sector, is headquartered in Germany and operates extensively across Europe. Founded in 2000, the company has established itself as a pioneer in genomic services, offering a comprehensive range of solutions including DNA sequencing, bioinformatics, and genetic analysis. GATC Biotech AG is renowned for its cutting-edge technologies and commitment to quality, which have positioned it as a trusted partner for academic institutions, pharmaceutical companies, and research organisations. With a focus on innovation, the company has achieved significant milestones, including the development of unique sequencing platforms that enhance accuracy and efficiency. As a prominent entity in the biotech industry, GATC Biotech AG continues to drive advancements in genomics, contributing to breakthroughs in personalised medicine and genetic research.
DitchCarbon Score
How does GATC Biotech AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GATC Biotech AG's score of 75 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GATC Biotech AG, headquartered in Germany, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Eurofins Scientific SE, which may influence its climate commitments and reporting practices. While GATC Biotech AG has not outlined specific reduction targets or initiatives, it is important to note that its parent company, Eurofins Scientific SE, is involved in various climate initiatives. These include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), which may indirectly impact GATC Biotech AG's climate strategies. As of now, GATC Biotech AG has not established its own specific climate pledges or reduction targets, indicating a potential area for future development in their sustainability efforts. The absence of reported emissions data suggests that the company may still be in the early stages of formalising its climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 72,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 155,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 311,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is GATC Biotech AG's Industry?
How Carbon Intensive is GATC Biotech AG's Location?
GATC Biotech AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
GATC Biotech AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.